Search

Your search keyword '"Colletti T."' showing total 75 results

Search Constraints

Start Over You searched for: Author "Colletti T." Remove constraint Author: "Colletti T."
75 results on '"Colletti T."'

Search Results

1. Association of Variants in the SPTLC1 Gene with Juvenile Amyotrophic Lateral Sclerosis

3. Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis

5. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis

6. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis

7. HFE p.H63D polymorphism does not influence ALS phenotype and survival

8. Genetic counselling in ALS: facts, uncertainties and clinical suggestions

9. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

10. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

11. ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion

12. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

13. CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients

14. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

15. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD

16. ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion

17. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis

18. Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72

19. TBK1 is associated with ALS and ALS-FTD in Sardinian patients

20. ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry

21. Indien

22. Indien

30. Recognizing the spectrum of illness in Epstein-Barr virus infection.

33. Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomized, double blind, placebo controlled, phase III study

34. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

35. Ataxin-1 and ataxin-2 intermediate-length PolyQ expansions in amyotrophic lateral sclerosis

36. ALS monocyte-derived microglia-like cells reveal cytoplasmic TDP-43 accumulation, DNA damage, and cell-specific impairment of phagocytosis associated with disease progression

37. CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis

38. Plasma cortisol level in amyotrophic lateral sclerosis

39. HFE p.H63D polymorphism does not influence ALS phenotype and survival

40. ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry

41. MTHFR C677T allelic variant is not associated to plasma and cerebrospinal fluid homocysteine in amyotrophic lateral sclerosis

42. Oxazoline functionalization of polyethylenes and their blends with polyamides and polyesters

43. TOXICITY OF B-N-OXALYLAMINO-L-ALANINE ANDB-N-METHYLAMINO-L-ALANINE IN NIH3T3 CELLS IS MEDIATED BY INHIBITIONOF THE XC¯ ANTIPORTER

44. URIC ACID LEVELS IN SERUM AND CSF OF ALS PATIENTS

45. Characteristics and career effect on PA graduates of a doctor of medical science program.

46. Cerebrospinal Fluid Neurofilaments Light-Chain Differentiate Patients Affected by Alzheimer's Disease with Different Rate of Progression (RoP): A Preliminary Study.

47. Evaluation of core Biomarkers of Alzheimer's disease in saliva and plasma measured by chemiluminescent enzyme immunoassays on a fully automated platform.

48. Curricula Mapping of Physician Associate/Physician Assistant-Comparable Professions Worldwide Using the Learning Opportunities, Objectives, and Outcomes Platform.

50. Biomarkers Related to Synaptic Dysfunction to Discriminate Alzheimer's Disease from Other Neurological Disorders.

Catalog

Books, media, physical & digital resources